熱門資訊> 正文
美国航空、OZK银行、Biohaven等上市前输家
2024-05-29 20:42
- AERWINS Technologies (AWIN) -35% on Q1 earnings release.
- Biohaven (BHVN) -30% after BHV-1510, a novel Trop-2 directed antibody drug conjugate, has shown promising preclinical efficacy and potential for wider therapeutic margin. The company has also entered a clinical supply agreement with Regeneron for Phase 1/2 clinical trial.
- Faraday Future Intelligent Electric FFIE -30% after reports FY results; withdraws production guidance for 2024.
- Onfolio Holdings (ONFO) -14%.
- OneMedNet (ONMD) -15%.
- Digital Turbine (APPS) -13% on Q4 earnings release.
- Predictive Oncology (POAI) -12% ahead of presentation at the BIO International Convention 2024.
- American Airlines (AAL) -9% on adjusted profit guidance cut.
- Bank OZK (OZK) -8%.
- Allot (ALLT) -8% on Q1 earnings release; appoints Liat Nahum as CFO.
- Renovaro (RENB) -7%.
- NuScale Power (SMR) -6%.
- Nano Nuclear Energy (NNE) -6%.
- MicroCloud Hologram (HOLO) -6% after files for $300M mixed securities shelf.
- CXApp (CXAI) -6%.
- SEALSQ (LAES) -6%.
- Akanda (AKAN) -5%.
- Intelligent Group (INTJ) -5%.
- See the biggest morning stock movers.
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
